Jiang Dai1,2,6, Yi-Jiao Huang2,6, Xinhua He1,6, Ming Zhao2, Xinzheng Wang2, Zhao-Shan Liu2, Wen Xue2, Hong Cai2, Xiao-Yan Zhan2, Shao-Yi Huang1,2, Kun He2, Hongxia Wang2, Na Wang2, Zhihong Sang2, Tingting Li2, Qiu-Ying Han2, Jie Mao2, Xinwei Diao2,3, Nan Song2, Yuan Chen2, Wei-Hua Li2, Jiang-Hong Man2, Ai-Ling Li2, Tao Zhou2, Zheng-Gang Liu4, Xue-Min Zhang1,2,5,*, Tao Li1,2,7*
1 State Key Laboratory of Toxicology and Medical Countermeasures, Institute of Pharmacology and Toxicology, National Center of Biomedical Analysis, 27 Tai-Ping Road, Beijing 100850, China
2 State Key Laboratory of Proteomics, Institute of Basic Medical Sciences, National Center of Biomedical Analysis, 27 Tai-Ping Road, Beijing 100850, China
3 Department of Pathology, Xinqiao Hospital, 3rd Military Medical University, Chongqing 400037, China
4 Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
5 Cancer Research Institute of Jilin University, the First Hospital of Jilin University, Changchun, Jilin Province 130021, China
6 These authors contributed equally
7 Lead Contact
